Novo says Wegovy pill outperforms Lilly's oral GLP-1
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images The Wegovy pill showed more pronounced weight loss…
CVS Health Corp.
Eli Lilly GLP-1 Foundayo pill approved for obesity
The US Food and Drug Administration has approved Eli LillyThe GLP-1 pill, the company said, is a major milestone for…
Novo Nordisk launches Wegovy subscription for GLP-1 anti-obesity drugs
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images Nordisk on Tuesday launched a multi-month subscription program…
Menstrual product prices soar due to inflation and tariffs
Always products are displayed on a shelf in a supermarket in Sarajevo, Bosnia and Herzegovina, on October 29, 2024. Ruvic…
ACA Enrollees Left Uninsured After Enhanced Subsidies Expire: KFF Survey
Many Americans are feeling the financial pain following the expiration of enhanced federal subsidies for health insurance from the Affordable…
Stopping GLP-1 increases cardiovascular risks: study
In a pharmacy you see boxes of Ozempic and Wegovy manufactured by Novo Nordisk. Hollie Adams | Reuters A version…
Eli Lilly Launches Program to Increase Employer Coverage of Obesity Drugs
Eli Lilly On Thursday it launched a new program designed to help more employers cover obesity medications in the U.S.,…
Why Novo Nordisk's expansion in Ireland is key to fighting Eli Lilly
Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production capabilities to…
Novo Nordisk to cut US list prices for Wegovy and Ozempic by up to 50%
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, on February…
Eli Lilly launches anti-obesity drug Zepbound with one-month dosage
An Eli Lilly & Co. Zepbound injection pen placed in the Brooklyn borough of New York on March 28, 2024.…